Life Sciences Vessels

Home / About Us Home / Investor Relations / Our Strategy / Our Market-Access Platforms / Life Sciences Vessels

Delivering solutions that enable life-changing, life-saving medicine

Corning has been a trusted supplier to the healthcare and pharmaceutical industries since we introduced PYREX® glass in 1915. Today, we are a leader in laboratory products, cell culture solutions, bioprocess vessels, and specialty surfaces. We are also helping to provide more reliable access to medicine with our revolutionary new glass packaging for drug storage and delivery.

Unparalleled Reputation for Quality, Consistency, and Reliability

With more than 100,000 customers, Corning products are standard equipment in nearly every Life Sciences laboratory in the world. Our product portfolio includes premium brands such as Falcon®, Axygen®, and PYREX®.

Sales
Outpacing

Corning’s existing Life Sciences business is growing faster than the market and has more than doubled sales since 2009.

In 2018, our Life Sciences Vessels grew at twice the market rate, showcasing record performance. But we anticipate even higher growth in the coming years, as the growth rate of the cell and gene therapy development industry continues to accelerate. The FDA is currently on track to approve 10-20 new cell and gene therapy products each year by 2025, and our unique HYPERStack® cell culture vessel solution has become the industry-leading solution to meet this demand.

Building a Long-term, Multi-billion Dollar Business

By drawing on our best-in-the-world capabilities and collaborating with long-time customers, we introduced Corning Valor® Glass, a revolutionary glass packaging for medicine. Valor dramatically reduces the probability of contamination by particles, breaks, and through cracks, while significantly increasing manufacturing throughput. It enhances the storage and delivery of today’s drug formulations and provides more reliable access to medicines essential to public health.

Corning remains closely engaged with its lead customers and the FDA. As Valor Glass progresses through regulatory approvals, Corning is investing in high-volume manufacturing to deliver this technology to customers. Valor Glass has the potential to drive growth for Corning for the next decade and beyond.

Current Market
Glass Challenges
Addressable Market Opportunity

The current market for pharmaceutical packaging, plus the pharmaceutical industry’s spend to address glass quality issues, combine to represent a significant addressable opportunity for Corning.

2020-2023 Objectives:

>2X industry growth and Valor® Glass franchise launch.

We are leveraging our deep customer relationships and core expertise to innovate and create long-term growth.

Life Sciences Vessels Platforms

Learn More About Our Life Sciences Vessels Market

News Releases and Web Disclosures

More >

Videos

More >

Presentations

More >